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Summary
Objectives: To determine the consistency between infor-
mation contained in the registration and publication of ran-
domised controlled trials (RCTs).
Design: An observational study of RCTs published between
May 2011 and May 2012 in the British Medical Journal (BMJ)
and the Journal of the American Medical Association (JAMA)
comparing registry data with publication data.
Participants and Settings: Data extracted from published
RCTs in BMJ and JAMA.
Main outcome measures: Timing of trial registration in
relation to completion of trial data collection and publica-
tion. Registered versus published primary and secondary
outcomes, sample size.
Results: We identified 40 RCTs in BMJ and 36 in JAMA. All
36 JAMA trials and 39 (98%) BMJ trials were registered.
All registered trials were registered prior to publication.
Thirty-two (82%) BMJ trials recorded the date of data com-
pletion; of these, in two trials the date of trial registration
postdated the registered date of data completion. There
were discrepancies between primary outcomes declared
in the trial registry information and in the published paper
in 18 (47%) BMJ papers and seven (19%) JAMA papers. The
original sample size stated in the trial registration was
achieved in 24 (60%) BMJ papers and 21 (58%) JAMA papers.
Conclusions: Compulsory registration of RCTs is meaning-
less if the content of registry information is not complete
or if discrepancies between registration and publication are
not reported. This study demonstrates that discrepancies
in primary and secondary outcomes and sample size
between trial registration and publication remain common-
place, giving further strength to the World Health
Organisation’s argument for mandatory completion of a
minimum number of compulsory fields.
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Background
Since 2004, clinical trial registration has been recom-
mended, and reputable medical journals claim to
insist on it.1 However, in practice registration may
be omitted, postdated, or information provided in
the trial registration may not correlate with the even-
tual trial publication. ‘Publication bias’ arises when
the results of trials are not published because of the
strength or direction of the results. ‘Outcome report-
ing bias’ refers to the selection for publication of a
subset of the originally chosen variables to be
reported based on the results.2 Both publication
and outcome reporting bias threaten the validity of
evidence-based medicine, and clinicians only have
access to the results which the researcher chooses to
publish. Strict, comprehensive registration of trials at
their outset allows the diﬀerences between what was
originally planned in the study and what is eventually
published to be seen, allowing critical evaluation of
the trial and minimising these two sources of bias.
A Cochrane Review in 2011 found that discrepan-
cies between trial registration and publication were
common and often not declared in the publication.2
The 2010 CONSORT checklist, a guide to what to
include when reporting clinical trials, includes ‘Any
changes to trial outcomes after the trial commenced,
with reasons’ which should provide further transpar-
ency. In a comprehensive review of the historical con-
text of biased reporting of clinical trials, Dickersin
and Chalmers3 conclude it is a ‘serious and extensive
problem, which threatens the best interests of
patients, undermines the scientiﬁc enterprise and
wastes resources’. Mathieu et al.4 in a survey of
reviewers of clinical trial manuscripts found that
only 34% had examined trial registry information
in the process of peer review. We sought to compare
trial registrations with trial publications from two
reputable general medical journals to see if anything
had changed.
Methods
We searched for randomised controlled trials (RCTs)
published between May 2011 and May 2012 in the
British Medical Journal (BMJ) and the Journal of the
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American Medical Association (JAMA) using the
journals’ respective webpages. We assessed
the abstracts of retrieved citations to determine if
the study was randomised. We deﬁned a randomised
study as a comparative study in which there is
random allocation of participants to an intervention
and a control group, with follow-up to examine dif-
ferences in outcomes between the two groups.5 We
excluded review articles, observational studies,
meta-analyses and follow-up studies.
We examined the corresponding trial registry
information using the trial registration number in
the published paper where it was available. Where a
trial registration number was unavailable, we
searched for trial registry information in the follow-
ing clinical trial registries: International Standard
Randomised Controlled Trial Number Register
(ISRCTN), ClinicalTrials.gov (NCT) and the registry
of the country of the ﬁrst author of the paper.
We collected data on whether the trial was regis-
tered, date of trial registration and date of trial pub-
lication, registered and published primary endpoints,
registered and published sample sizes, registered and
published statistical analysis plans and whether dis-
crepancies were declared in the published paper.
We read the full-text articles of all RCTs and com-
pared trial registry information with information
from the corresponding trial publication. Where
available, we examined the archived trial registry
data, looking for changes to the registration to see
whether changes had been made to the registry post
trial publication.
Results
We identiﬁed 40 RCTs in BMJ and 36 in JAMA. All
36 JAMA trials and 39 (98%) BMJ trials were regis-
tered, only one trial was unregistered. This was a trial
of sildenaﬁl citrate use for pulmonary arterial hyper-
tension, and the paper reported on the ocular safety of
the drug. In the publication arising from this trial, two
diﬀerent trial registrations numbers were reported but
neither referred to an RCT where ocular safety was an
outcome measure (primary or secondary).
All 39 BMJ trials that were registered were regis-
tered prior to publication. Thirty-two (82%) BMJ
trials recorded the anticipated or actual date of out-
come data completion. In 31 of those trials, the date
of data completion proceeded the date of trial publi-
cation by an average of 24 months (range 7–56
months). One trial registered an anticipated date of
data completion nine months post the date of trial
publication. In two out of 32 trials, the date of trial
registration postdated the registered date of data
completion (by 5 and 6 months). Excluding these
two trials, the average time between trial registration
and date of data completion was 27 months (range 5–
63 months).
All 36 JAMA trials that were registered were regis-
tered prior to publication. Thirty-three (92%) JAMA
trials recorded the date of outcome data completion.
Of those, in 31 trials the date of data collection pre-
ceded the date of trial publication by an average of 21
months. In two trials, the registered anticipated date of
data completion postdated the date of trial publication
(by 8 months and 47 months). All 31 trials were regis-
tered before the date of data completion with an aver-
age time of 46 months (range 3–142 months).
There were discrepancies between primary out-
comes declared in the trial registry information and
in the published paper in 18 BMJ papers (47%) and
seven JAMA papers (19%). The discrepancies are
listed in Table 1.
The original sample size stated in the trial registra-
tion was achieved in 24 (60%) of BMJ papers and 21
(58%) of JAMA papers. Of those RCTs where the
sample size was not achieved, the sample size was
underachieved by <10% in 7/11 studies in BMJ
and 3/14 studies in JAMA (Table 2). Of those studies
where the sample size was not achieved, this was
openly disclosed in the trial publication in 4/16
BMJ papers and 4/15 JAMA papers.
We did not ﬁnd evidence of a registered statistical
analysis plan for any of the trials we included from
BMJ and only one trial in JAMA provided details of
their statistical analysis plan in the trial registration.
Discussion
Compulsory registration of RCTs is meaningless if the
content of registry information is not complete or if
discrepancies between registration and publication
are not reported. This study demonstrates that while
the majority of published RCTs in major journals are
registered in a timely fashion, discrepancies in primary
and secondary outcomes and sample size between trial
registration and publication are commonplace, and
often not mentioned in the published paper.
Although the Cochrane Review included 16 stu-
dies with a median number of 54 RCTs, many
people believe there has been a recent improvement.
Our study of 76 RCTs is larger than the average of
the studies included in the Cochrane Review and
more up to date.
The papers from the two journals were examined
by only one author (KW, BMJ; GS, JAMA). It
would have added more scientiﬁc rigour if each
paper had been examined separately by two authors.
In a study of 110 RCTS published in 2009 com-
paring trial registry information with trial
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publication, Ewart et al.6 found that in 31% of trials
a primary outcome had been changed, and in 70% of
trials a secondary outcome had been changed.
Mathieu et al.7 in a similar paper published in 2009
examining 147 studies found a discrepancy in primary
outcome between registration and publication in 31%
of studies. We found discrepancies in the primary
outcome in 33% of trials. Ewart et al.6 clearly state
that they examined trial registry data as it appeared
on the day of examination of the registry but did not
examine changes to trial registration in the archive.
We did examine archived trial registry information
looking for changes that may have resulted in a
greater number of discrepancies being uncovered
and why there has been no improvement in discre-
pancies since the publication of the Cochrane
Review. Hannink et al.8 in a study of 327 surgical
RCTs found that only 152 trials were registered
before the end of the trial. Of those 152 trials, 75
(49%) showed evidence of a discrepancy between
registered and published outcomes. And in 28% of
the trials, these discrepancies favoured statistically
signiﬁcant results. Ross et al.10 scrutinised the com-
pleteness of trial registry information in
ClinicalTrials.gov and found that while compulsory
data sets were completed nearly 100% of the time,
when it came to optional data sets reporting was
varied: principal investigator name (63%), enrolment
(82%), start date (87%), end date (53%), primary
outcome measure (66%) and secondary outcome
measure (56%). Huic et al.9 in a study of 149 RCTs
found that 77.6% of RCTs had a diﬀerent sample
size recorded in the registration data than in the pub-
lished data.9
This paper gives further strength to the argument
that the World Health Organisation Minimal
Registration Data set should be adopted by trial
registries and journals so that compulsory ﬁelds are
completed when a trial is registered (WHO Trial
Registration Data Set Version 1.2.1). Reveiz et al.11
make the argument that making trial protocols pub-
licly available would expose the full methodological
detail of trials and improve the ability of journals to
critically appraise the reporting of trials.
It is well established that clinical trials reporting
positive outcomes are more likely to be published
than those that feature negative results. But the inclu-
sion of positive outcomes can also inﬂuence the speed
of publication and the accessibility of the work.3
It would be interesting to know whether there is a
similar correlation between trials with discrepancies
in primary and secondary outcomes from registration
Table 1. Discrepancies between registered and published primary outcomes.
Registered and published primary outcomes BMJ (39) JAMA (36)
No discrepancy between registered and published primary outcome 21 (53%) 29 (81%)
No primary outcome registered 2 (5%) 1 (3%)
Change in timing of the assessment of the primary outcome 4 (10%) 1 (3%)
New primary outcome introduced in the paper 7 (18%) 3 (8%)
Registered primary outcome not reported in the paper 2 (5%) 0
Registered primary endpoint reported as secondary outcome in the paper 1 (3%) 1 (3%)
Registered primary endpoint reported in a previous publication 1 (3%) 0
Registered secondary outcome reported as a primary outcome in the paper 1 (3%) 0
Change in study population 0 1 (3%)
Table 2. Discrepancies between registered and published
sample size.
Sample size BMJ (40) JAMA (36)
Sample size achieved 24 (60%) 21 (58%)
Sample size not achieved 11 (28%) 14 (39%)
By >10% 4 11
By <10% 7 3
Sample size not registered 2 (5%) 0
Registered SS changed
to actual SS achieved
3 (8%) 1 (3%)
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to publication and an increased likelihood of report-
ing positive outcomes than trials that stick to their
registered intentions.
Conclusion
It is clear that compulsory registration without scru-
tiny of the registration contents leads to widespread
discrepancies in the trial registration and eventual
trial publication. Registration should be a more strin-
gent exercise, where certain ﬁelds are compulsory.
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